Taiyen Biotech Co Ltd Financial Flexibility Index
Taiyen Biotech Co Ltd financial flexibility index. Taiyen Biotech Co Ltd (1737) has a Financial Flexibility Index of 0.08x as of June 2026. Free cash flow of NT$137.82 Million (operating CF NT$99.80 Million minus capex NT$38.03 Million) represents 0% of total liabilities (NT$1.67 Billion). See 1737 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Taiyen Biotech Co Ltd (2003–2025)
Financial flexibility index of Taiyen Biotech Co Ltd from 2003 to 2025. Historical Financial Flexibility Index trend for Taiyen Biotech Co Ltd across 23 annual periods. Check earnings quality score of Taiyen Biotech Co Ltd to evaluate the quality of earnings relative to operating cash generation.
Taiyen Biotech Co Ltd Financial Flexibility Index by Year (2003–2025)
Taiyen Biotech Co Ltd financial flexibility index by year from 2003 to 2025. Year-by-year free cash flow to debt coverage for Taiyen Biotech Co Ltd. For the full cash flow conversion analysis, see cash efficiency ratio of Taiyen Biotech Co Ltd.
| Year | Flexibility Index | Free Cash Flow (TWD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.53x | NT$773.93 Million | NT$473.77 Million | NT$1.45 Billion | ▼ -5.4% |
| 2024 | 0.56x | NT$967.73 Million | NT$660.12 Million | NT$1.71 Billion | ▲ +25.1% |
| 2023 | 0.45x | NT$799.67 Million | NT$454.54 Million | NT$1.77 Billion | ▼ -15.4% |
| 2022 | 0.53x | NT$827.29 Million | NT$580.69 Million | NT$1.55 Billion | ▲ +5.3% |
| 2021 | 0.51x | NT$990.89 Million | NT$600.08 Million | NT$1.95 Billion | ▲ +19.7% |
| 2020 | 0.42x | NT$607.25 Million | NT$339.36 Million | NT$1.43 Billion | ▼ -0.2% |
| 2019 | 0.42x | NT$615.06 Million | NT$330.81 Million | NT$1.45 Billion | ▼ -33.6% |
| 2018 | 0.64x | NT$748.32 Million | NT$449.83 Million | NT$1.17 Billion | ▼ -19.6% |
| 2017 | 0.80x | NT$977.55 Million | NT$607.87 Million | NT$1.23 Billion | ▲ +12.0% |
| 2016 | 0.71x | NT$758.36 Million | NT$568.06 Million | NT$1.07 Billion | ▲ +43.5% |
| 2015 | 0.50x | NT$490.50 Million | NT$383.93 Million | NT$990.08 Million | ▼ -13.0% |
| 2014 | 0.57x | NT$519.87 Million | NT$371.06 Million | NT$913.15 Million | ▼ -16.2% |
| 2013 | 0.68x | NT$296.74 Million | NT$203.21 Million | NT$436.66 Million | ▼ -11.8% |
| 2012 | 0.77x | NT$263.86 Million | NT$154.46 Million | NT$342.49 Million | ▼ -14.9% |
| 2011 | 0.91x | NT$322.94 Million | NT$246.09 Million | NT$356.53 Million | ▼ -21.6% |
| 2010 | 1.16x | NT$426.96 Million | NT$300.89 Million | NT$369.36 Million | ▼ -19.5% |
| 2009 | 1.44x | NT$472.69 Million | NT$358.02 Million | NT$329.10 Million | ▼ -27.8% |
| 2008 | 1.99x | NT$609.60 Million | NT$417.51 Million | NT$306.42 Million | ▲ +82.0% |
| 2007 | 1.09x | NT$402.19 Million | NT$322.49 Million | NT$367.92 Million | ▼ -11.1% |
| 2006 | 1.23x | NT$611.33 Million | NT$462.88 Million | NT$497.10 Million | ▲ +61.5% |
| 2005 | 0.76x | NT$705.10 Million | NT$575.91 Million | NT$925.79 Million | ▼ -49.9% |
| 2004 | 1.52x | NT$3.03 Billion | NT$2.84 Billion | NT$1.99 Billion | ▲ +80.1% |
| 2003 | 0.84x | NT$3.51 Billion | NT$3.42 Billion | NT$4.16 Billion | — |